Geisler, Daniel
Ritschel, Franziska
King, Joseph A.
Bernardoni, Fabio
Seidel, Maria
Boehm, Ilka
Runge, Franziska
Goschke, Thomas
Roessner, Veit
Smolka, Michael N.
Ehrlich, Stefan
Article History
Received: 15 August 2016
Accepted: 7 December 2016
First Online: 13 February 2017
Competing interests
: In the last two years, Dr. Roessner has received payment for consulting and writing activities from Lilly, Novartis, and Shire Pharmaceuticals, lecture honoraria from Lilly, Novartis, Shire Pharmaceuticals, and Medice Pharma, and support for research from Shire and Novartis. He has carried out (and is currently carrying out) clinical trials in cooperation with the Novartis, Shire, and Otsuka companies.